Skip to Main Content

Author Details

John V Pearson
QIMR Berghofer Medical Research Institute
1996
101
46
PMIDPaper TitleJournal TitlePublished Year
36757207Efficient detection and monitoring of pediatric brain malignancies with liquid biopsy based on patient-specific somatic mutation screening.Neuro Oncol2023
36656928Heritable defects in telomere and mitotic function selectively predispose to sarcomas.Science2023
37149669Generalising uncertainty improves accuracy and safety of deep learning analytics applied to oncology.Sci Rep2023
36757207Efficient detection and monitoring of pediatric brain malignancies with liquid biopsy based on patient-specific somatic mutation screening.Neuro Oncol2023
36868206Australian Genomics: Outcomes of a 5-year national program to accelerate the integration of genomics in healthcare.Am J Hum Genet2023
37149669Generalising uncertainty improves accuracy and safety of deep learning analytics applied to oncology.Sci Rep2023
36656928Heritable defects in telomere and mitotic function selectively predispose to sarcomas.Science2023
36868206Australian Genomics: Outcomes of a 5-year national program to accelerate the integration of genomics in healthcare.Am J Hum Genet2023
35012638Patient-derived xenograft models capture genomic heterogeneity in endometrial cancer.Genome Med2022
36098958Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes.Cancer Discov2022
36291058Identifying Candidate Circulating RNA Markers for Coronary Artery Disease by Deep RNA-Sequencing in Human Plasma.Cells2022
36095262Analysis of hereditary cancer gene variant classifications from ClinVar indicates a need for regular reassessment of clinical assertions.Hum Mutat2022
36222710Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes.Clin Cancer Res2022
35637530Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma.Genome Med2022
36332611Shariant platform: Enabling evidence sharing across Australian clinical genetic-testing laboratories to support variant interpretation.Am J Hum Genet2022
35355015Anatomic position determines oncogenic specificity in melanoma.Nature2022
35849877Comparison of actionable events detected in cancer genomes by whole-genome sequencing, in silico whole-exome and mutation panels.ESMO Open2022
36699384qmotif: determination of telomere content from whole-genome sequence data.Bioinform Adv2022
35012638Patient-derived xenograft models capture genomic heterogeneity in endometrial cancer.Genome Med2022
34951955Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance.Cancer Cell2022
35637530Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma.Genome Med2022
35849877Comparison of actionable events detected in cancer genomes by whole-genome sequencing, in silico whole-exome and mutation panels.ESMO Open2022
35355015Anatomic position determines oncogenic specificity in melanoma.Nature2022
36699384qmotif: determination of telomere content from whole-genome sequence data.Bioinform Adv2022
36332611Shariant platform: Enabling evidence sharing across Australian clinical genetic-testing laboratories to support variant interpretation.Am J Hum Genet2022
36098958Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes.Cancer Discov2022
36095262Analysis of hereditary cancer gene variant classifications from ClinVar indicates a need for regular reassessment of clinical assertions.Hum Mutat2022
36291058Identifying Candidate Circulating RNA Markers for Coronary Artery Disease by Deep RNA-Sequencing in Human Plasma.Cells2022
36222710Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes.Clin Cancer Res2022
34951955Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance.Cancer Cell2022
34579788Deep learning in cancer diagnosis, prognosis and treatment selection.Genome Med2021
33811161Radiomics Biomarkers Correlate with CD8 Expression and Predict Immune Signatures in Melanoma Patients.Mol Cancer Res2021
33514769Verifying explainability of a deep learning tissue classifier trained on RNA-seq data.Sci Rep2021
33600021Considerations for using population frequency data in germline variant interpretation: Cancer syndrome genes as a model.Hum Mutat2021
33917078Tumor Signature Analysis Implicates Hereditary Cancer Genes in Endometrial Cancer Development.Cancers (Basel)2021
34579788Deep learning in cancer diagnosis, prognosis and treatment selection.Genome Med2021
34732514Ask the people: developing guidelines for genomic research with Aboriginal and Torres Strait Islander peoples.BMJ Glob Health2021
33600021Considerations for using population frequency data in germline variant interpretation: Cancer syndrome genes as a model.Hum Mutat2021
33514769Verifying explainability of a deep learning tissue classifier trained on RNA-seq data.Sci Rep2021
33811161Radiomics Biomarkers Correlate with CD8 Expression and Predict Immune Signatures in Melanoma Patients.Mol Cancer Res2021
33917078Tumor Signature Analysis Implicates Hereditary Cancer Genes in Endometrial Cancer Development.Cancers (Basel)2021
34732514Ask the people: developing guidelines for genomic research with Aboriginal and Torres Strait Islander peoples.BMJ Glob Health2021
32384699<i>APC</i> Mutation Marks an Aggressive Subtype of <i>BRAF</i> Mutant Colorectal Cancers.Cancers (Basel)2020
32415113Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumours.Nat Commun2020
31935636Alterations in signaling pathways that accompany spontaneous transition to malignancy in a mouse model of BRAF mutant microsatellite stable colorectal cancer.Neoplasia2020
32384699<i>APC</i> Mutation Marks an Aggressive Subtype of <i>BRAF</i> Mutant Colorectal Cancers.Cancers (Basel)2020
32818150Using whole-genome sequencing data to derive the homologous recombination deficiency scores.NPJ Breast Cancer2020
32917657Tumor Mutation Burden and Structural Chromosomal Aberrations Are Not Associated with T-cell Density or Patient Survival in Acral, Mucosal, and Cutaneous Melanomas.Cancer Immunol Res2020
33067454Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity.Nat Commun2020
31935636Alterations in signaling pathways that accompany spontaneous transition to malignancy in a mouse model of BRAF mutant microsatellite stable colorectal cancer.Neoplasia2020
  • 1 - 50 of 202

Recommended Authors

Department of Biology at Brigham Young University
Career Start Year 2013
Number of shared co-authors 14
University of Melbourne, The University of Melbourne
Career Start Year 2011
Number of shared co-authors 16
University of Pennsylvania
Career Start Year 2010
Number of shared co-authors 19
Departments of Bioinformatics and Clinical Genomics, Illumina Inc.
Career Start Year 2009
Number of shared co-authors 14
University of Texas MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 19
Institute of Genetics and Cancer, University of Edinburgh
Career Start Year 2006
Number of shared co-authors 15
The Broad Institute of Harvard and MIT
Career Start Year 2005
Number of shared co-authors 19
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 32
Uniformed Services University of the Health Sciences
Career Start Year 2004
Number of shared co-authors 21
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 25
University of California
Career Start Year 2003
Number of shared co-authors 8
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 45
Washington University
Career Start Year 2003
Number of shared co-authors 19
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 37
University of Texas M.D. Anderson Cancer Center
Career Start Year 2001
Number of shared co-authors 10
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 14
Broad Institute of MIT and Harvard
Career Start Year 2001
Number of shared co-authors 52
Institute for Computational Biomedicine
Career Start Year 2000
Number of shared co-authors 9
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 12
Broad Institute of the Massachusetts Institute of Technology and Harvard
Career Start Year 2000
Number of shared co-authors 54
National Human Genome Research Institute, National Institutes of Health
Career Start Year 2000
Number of shared co-authors 12
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 22
St. Jude Children's Research Hospital
Career Start Year 1999
Number of shared co-authors 11
The Broad Institute of Harvard and MIT
Career Start Year 1998
Number of shared co-authors 35
University of British Columbia
Career Start Year 1995
Number of shared co-authors 74
Frederick National Laboratory for Cancer Research
Career Start Year 1994
Number of shared co-authors 31
University of British Columbia
Career Start Year 1993
Number of shared co-authors 71
Mayo Clinic
Career Start Year 1991
Number of shared co-authors 3
The Ohio State University
Career Start Year 1988
Number of shared co-authors 43
University of California, USA Institute for Genomic Medicine
Career Start Year 1967
Number of shared co-authors 7

Collaborators

QIMR Berghofer Medical Research Institute
Co-authored papers 68
QIMR Berghofer Medical Research Institute
Co-authored papers 41
QIMR Berghofer Medical Research Institute
Co-authored papers 41
The University of Melbourne
Co-authored papers 30
University of Southern California
Co-authored papers 21
Adelaide Medical School, The University of Adelaide
Co-authored papers 17
QIMR Berghofer Medical Research Institute
Co-authored papers 15
The University of Queensland Diamantina Institute, The University of Queensland
Co-authored papers 15
The Translational Genomics Research Institute (TGen)
Co-authored papers 14
Co-authored papers 13
Garvan Institute of Medical Research and The Kinghorn Cancer Centre
Co-authored papers 13
Children's Cancer Institute, Lowy Cancer Research Centre
Co-authored papers 12
Banner Alzheimer's Institute
Co-authored papers 11
Co-authored papers 10
UQ Centre for Clinical Research, The University of Queensland
Co-authored papers 9
University of Queensland
Co-authored papers 8
College of American Pathologists
Co-authored papers 8
Queensland University of Technology
Co-authored papers 8
QIMR Berghofer Medical Research Institute
Co-authored papers 7
National Centre for Asbestos Related Diseases, University of Western Australia
Co-authored papers 6
Baylor College of Medicine
Co-authored papers 6
Westmead Clinical School, University of Sydney
Co-authored papers 6
Peter MacCallum Cancer Centre
Co-authored papers 6
Westmead Hospital
Co-authored papers 6
The Westmead Institute for Medical Research, University of Sydney
Co-authored papers 6
Westmead Hospital
Co-authored papers 5
Baylor College of Medicine
Co-authored papers 5
Peter MacCallum Cancer Centre
Co-authored papers 5
Peter MacCallum Cancer Centre
Co-authored papers 5
Peter MacCallum Cancer Centre
Co-authored papers 4